AI Physical Therapy AI Designer Interview Questions

A strong answer explains the International Classification of Functioning, Disability and Health - body functions/structures, activities, participation, environmental/personal factors - and why AI systems must model this multidimensional framework rather than just diagnosing pathology.

Answer should cover IMU tri-axial accelerometer/gyroscope data for ambulatory movement tracking versus force plate ground-reaction-force measurement for controlled clinical tests, and the trade-offs in ecological validity versus measurement precision.

Great answers address PHI classification of movement data, encryption at rest and in transit, access controls, audit logging, Business Associate Agreements, and the difference between de-identified and anonymized data.

Should clarify that ODI is a specific PROM for low back pain, explain the broader PROM category, and discuss how AI systems need to standardize, collect, and interpret these validated instruments rather than inventing unvalidated metrics.

Strong answers cover the pipeline from image input through person detection to keypoint localization, producing 2D/3D landmark coordinates for body joints, and discuss confidence scores and occlusion challenges.

Excellent answers include video/sensor data collection protocol, keypoint extraction, biomechanical feature derivation (trunk lean angle, knee valgus, hip drop), model options (XGBoost for tabular, CNN-LSTM for raw sequences), and clinician-annotated ground truth with inter-rater reliability metrics.

Cover data augmentation strategies (synthetic movement generation, time-warping), SMOTE variants for time-series, focal loss, stratified cross-validation, and the clinical importance of optimizing recall for compensatory patterns to avoid missing at-risk patients.

Should address document chunking of CPGs, embedding with domain-specific models, vector store selection, retrieval filtering by condition and evidence grade, LLM response generation with safety guardrails, and citation of sources for clinical trust.

Great answers discuss domain shift from lighting, camera angle, clothing, occlusion from furniture, varied body types and movement speeds, and strategies like domain adaptation, data augmentation, and few-shot fine-tuning with home-environment data.

Should cover concurrent validity (correlation with gold-standard clinical tests), construct validity, test-retest reliability, minimal detectable change, sensitivity/specificity at clinically relevant thresholds, and the importance of Bland-Altman analysis for continuous measurements.

Cover the full pipeline: camera input, on-device or edge inference for pose estimation, movement quality scoring, feedback generation (visual overlay, audio cue, haptic), latency constraints (<100ms for real-time feel), and fallback handling for poor connectivity.

Strong answers discuss FHIR resource types (Observation, Condition, CarePlan), API integration patterns, data normalization and timestamp alignment between EMR discrete data and high-frequency sensor streams, and handling missing or irregular EMR entries.

Cover simplified UI/UX, voice-first interaction design, larger text and high-contrast visuals, redundant feedback channels, caregiver integration, tolerance for slower and variable movement speeds, and ethical consent frameworks for cognitively impaired users.

Should define the state space (patient progress metrics, pain levels, range of motion), action space (exercise type, sets, reps, resistance), reward function (balanced between recovery speed and safety), and discuss exploration-exploitation trade-offs in safety-critical healthcare.

Address training data diversity, stratified performance evaluation across demographics, fairness metrics (equalized odds, demographic parity), bias auditing pipelines, clinical validation across subgroups, and the documented limitations of pose-estimation models for different skin tones and body compositions.

Expert answers cover SaMD risk categorization (FDA framework), predicate or reference device selection, software documentation (IEC 62304), clinical evidence requirements, cybersecurity documentation, quality management system (ISO 13485), and post-market surveillance planning.

Should cover federated averaging, differential privacy guarantees, secure aggregation, communication efficiency with large video-model parameter sets, non-IID data challenges across clinics with different patient populations, and aggregation strategies that handle clinic-level distribution shift.

Expert answers discuss early vs. late fusion strategies, attention-based cross-modal architectures, handling asynchronous and heterogeneous data streams, missing modality robustness, and how to weight subjective (PROMs) versus objective (sensor) signals in the final assessment.

Should cover active learning with clinician-in-the-loop annotation, few-shot and zero-shot transfer from pre-trained pose models, synthetic data generation from biomechanical simulations, progressive model improvement with each clinician interaction, and confidence-based routing to human assessment.

Cover RCT design (parallel group, blinding feasibility, randomization), primary and secondary endpoints (functional outcomes, pain, adherence, cost), sample size calculation, intention-to-treat analysis, non-inferiority or superiority margins, and ethical considerations of an AI-comparator arm.

Discuss SHAP/LIME explanations for movement classifiers, attention visualization on body keypoints, clinically meaningful feature explanations (not just mathematical), the trade-off with end-to-end deep learning performance, and designing explanation interfaces that match clinician mental models.

Cover data drift detection (population shift, sensor hardware variation), performance degradation alerting, staged rollout of model updates, A/B testing in production, rollback strategies, versioning of model and data, and the regulatory implications of post-deployment model modifications.

Expert answers discuss OpenSim or MuJoCo musculoskeletal modeling, patient-specific model calibration from motion capture and imaging data, physics-informed neural networks, simulation of exercise loads on tissue healing timelines, and the clinical workflow for therapist interaction with the digital twin.

Should address current IP law limitations on AI-generated inventions, patentability of algorithmic processes, data ownership frameworks, contractual structures between vendors and health systems, and emerging legal debates around AI authorship in clinical protocols.

Cover cost modeling at scale, latency requirements for real-time biofeedback, data privacy implications of cloud processing, accuracy comparison on rehab-specific movements (not just generic poses), model customization flexibility, offline capability needs, and vendor lock-in risks.

Strong answers involve reviewing the specific failure cases, checking if the model captures compensatory lumbar extension (may not have been trained on it), requesting video examples for relabeling, analyzing feature importance to see if trunk angle features are weighted appropriately, and iterating the training data and model.

Cover immediate response (chatbot takedown, patient outreach), root cause analysis (prompt engineering gap, safety guardrail failure, pain-severity classification error), mitigation (pain-escalation thresholds, mandatory therapist escalation for sharp pain reports), and long-term prevention (adversarial testing, clinical review board for prompt templates).

Should discuss a tiered deployment approach: smartphone-only mode using phone cameras for broad deployment, enhanced mode with dedicated cameras for specialized clinics, ensuring consistent assessment quality across tiers, and a hardware upgrade roadmap with ROI justification for the hospital.

Discuss encoding clinical protocols as hard constraints in the prescription engine, importing surgeon-specific and condition-specific rehab protocols as rule layers, clinician override capabilities, and the design pattern of separating AI recommendations from constraint enforcement.

Cover technical fixes (data augmentation with diverse body compositions, fine-tuning on underrepresented groups, ensemble methods), ethical framing (avoiding weight bias in healthcare AI, equity implications), stakeholder communication, and accelerated data collection from diverse body types with proper IRB approval.

Address scope creep management, the critical difference between movement quality classification and injury prediction (different evidence base, much higher liability), need for prospective longitudinal data, regulatory implications of risk prediction claims, and a phased roadmap with clear feasibility milestones.

Cover LLM-based translation with clinical terminology verification, cultural adaptation of feedback tone (directness varies by culture), collaboration with local PT professionals for clinical validation, handling non-English text in NLP pipelines, and regulatory requirements in the Japanese market (PMDA).

Discuss possible explanations (therapists over-relying on AI, less hands-on time, patients feeling deprioritized), the danger of optimizing for productivity at the expense of therapeutic alliance, design modifications to enhance patient experience, and honest communication of trade-offs to stakeholders.

Cover evidence-based differentiation (publish your validation studies, comparative effectiveness data), total cost of ownership analysis including false-positive costs, regulatory readiness as a competitive moat, customer reference strategy, and the long-term reputational risk of under-validated competitors.

Discuss alert severity tiers, evidence-based deterioration thresholds calibrated to minimal clinically important difference (MCID), contextual alerting that includes supporting data trends, therapist feedback loops to improve alert precision, and the UI design challenge of surfacing alerts at the right moment.

Should cover data labeling (CVAT, Label Studio), experiment tracking (Weights & Biases), training (PyTorch on AWS SageMaker), validation (clinical test set with inter-rater reliability), containerization (Docker), deployment (SageMaker endpoints or on-device TFLite), monitoring (Evidently AI for drift), and CI/CD (GitHub Actions).

Cover document loaders for PDF CPGs, text splitting strategies, embedding with sentence-transformers or OpenAI embeddings, vector store selection (Pinecone, Chroma), retrieval chain with source attribution, prompt templates with safety guardrails, and output parsers for structured exercise recommendations.

Cover frame capture, preprocessing (resize, normalize), on-device inference (TFLite or CoreML for mobile), post-processing (keypoint smoothing, angle calculation), feedback generation, and total latency budget of ~100ms, with specific tools like MediaPipe Pose for the heavy lifting and techniques like frame skipping under load.

Cover logging training/validation loss and accuracy curves, confusion matrices stratified by movement type, ROC curves for different compensation categories, model artifacts (checkpoints, ONNX exports), dataset versioning, and custom metrics like clinically-defined false-negative rate.

Should describe AWS IoT Core for device ingestion, Kinesis or IoT Analytics for streaming, S3 data lake with partitioning strategy, Glue for ETL, Athena for ad-hoc queries, SageMaker Feature Store for feature management, and the streaming-versus-batch dual-path architecture.

Cover annotation tool selection (CVAT, Label Studio), rubric design with clear criteria and examples, calibration sessions, dual-annotation with adjudication for disagreement, Cohen's kappa monitoring, active learning to prioritize uncertain samples for expert review, and integration with training pipeline.

Cover model selection (BioBERT, ClinicalBERT, or fine-tuned T5), dataset preparation with clinical NER annotation, fine-tuning with HuggingFace Trainer API, evaluation with clinical entity-level F1 scores, deployment via HuggingFace Inference Endpoints, and integration with downstream recommendation engines.

Cover MLflow or SageMaker Model Registry for version management, canary deployment strategy, shadow mode testing (running new model in parallel without serving its predictions), A/B traffic splitting, guardrail metrics (accuracy drop triggers rollback), and clinical impact monitoring dashboards.

Cover OpenSim or MuJoCo for musculoskeletal simulation, parameterized movement generation with variations in speed, amplitude, and compensation patterns, domain randomization for visual realism, validation that synthetic movements are biomechanically plausible, and mixing strategies for synthetic-real dataset composition.

Cover structured prompt templates with role-based instructions, retrieval of condition-specific CPG evidence, constraint injection (surgical protocols, pain thresholds, equipment availability), output parsing into structured exercise plans, clinician review workflow, and adversarial testing for harmful or contraindicated recommendations.

A strong answer demonstrates courage in pushing back with evidence, ability to propose alternatives (phased rollout, limited pilot), collaboration with clinical advisors, and a learning mindset about the tension between speed-to-market and patient safety.

Should show structured learning approach (literature review, expert interviews, clinical observation), humility about knowledge gaps, ability to translate clinical needs into technical requirements, and the impact of domain learning on product quality.

Great answers show respect for clinical expertise, use of evidence and demonstrations rather than dogma, acknowledgment of valid concerns (deskilling, liability, therapeutic relationship), and a collaborative framing where AI augments rather than replaces clinical judgment.

Should cover immediate incident response, transparent communication with stakeholders, root cause analysis, fix implementation, post-mortem process, and systemic improvements to prevent recurrence - demonstrating ownership and accountability.

Strong answers reference specific practices: following key conferences (NeurIPS, APTA CSM), reading journals (JOSPT, Nature Medicine), engaging in cross-disciplinary communities, hands-on experimentation with new tools, and maintaining relationships with clinical collaborators who provide reality checks.